Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
Frontiers in Physiology|August 9, 2021
Potentiation of Acetylcholine-Induced Relaxation of Aorta in Male UC Davis Type 2 Diabetes Mellitus (UCD-T2DM) Rats: Sex-Specific ResponsesFarjana Akther, Md Rahatullah Razan, Sonali Shaligram, et al.
European Journal of Pharmacology|April 23, 2020
Mesenteric arterial dysfunction in the UC Davis Type 2 Diabetes Mellitus rat model is dependent on pre-diabetic versus diabetic status and is sexually dimorphicSonali Shaligram, Farjana Akther, Md Rahatullah Razan, et al.
The Journal of Clinical Endocrinology and Metabolism|August 9, 2012
Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humansAndrew A Butler, Charmaine S Tam, Kimber L Stanhope, et al.
Experimental Physiology|May 5, 2026
Inflammation, mechanical allodynia and an exaggerated exercise pressor reflex during disease progression in UCD-type 2 diabetes mellitus ratsMichelle L Harrison, Richard K McCuller, Yu Huo, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 18, 2016
Triglyceride content in remnant lipoproteins is significantly increased after food intake and is associated with plasma lipoprotein lipaseKatsuyuki Nakajima, Yoshiharu Tokita, Koji Sakamaki, et al.
The Journal of Nutrition|January 31, 2014
DNA methylation patterns are associated with n-3 fatty acid intake in Yup'ik peopleStella Aslibekyan, Howard W Wiener, Peter J Havel, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 3, 2011
Postprandial lipoprotein metabolism: VLDL vs chylomicronsKatsuyuki Nakajima, Takamitsu Nakano, Yoshiharu Tokita, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 26, 2016
The majority of lipoprotein lipase in plasma is bound to remnant lipoproteins: A new definition of remnant lipoproteinsKoichi Sato, Fumikazu Okajima, Kazuya Miyashita, et al.
Diabetes|July 13, 2010
Chronic administration of the glucagon-like peptide-1 analog, liraglutide, delays the onset of diabetes and lowers triglycerides in UCD-T2DM ratsBethany P Cummings, Kimber L Stanhope, James L Graham, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|October 4, 2008
Development and characterization of a novel rat model of type 2 diabetes mellitus: the UC Davis type 2 diabetes mellitus UCD-T2DM ratBethany P Cummings, Erin K Digitale, Kimber L Stanhope, et al.
Pageof 12